Cargando…
The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy
The HIV-1 virus (human immunodeficiency virus) affects 36.9 million people worldwide, with approximately 900000 deaths in 2017. The virus carrier can develop severe immunodeficiency since CD4(+) T lymphocytes are the main target, leading to acquired immunodeficiency syndrome (AIDS). Despite advances...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721108/ https://www.ncbi.nlm.nih.gov/pubmed/31531340 http://dx.doi.org/10.1155/2019/8458263 |